Vaccination strategies using viable carrier systems against intracellular pathogens.
Hess
J
J
Abteilung für Immunologie, Universität Ulm, Germany.
Szalay
G
G
Miko
D
D
Gentschev
I
I
Goebel
W
W
Ladel
C H
CH
Kaufmann
S H
SH
D000818:Animals; D003140:Communicable Disease Control; D015195:Drug Design; D006681:HLA-D Antigens / Q000276:immunology; D015395:Histocompatibility Antigens Class I / Q000276:immunology; D006801:Humans; D008089:Listeria monocytogenes / Q000276:immunology / Q000472:pathogenicity; D008088:Listeriosis / Q000276:immunology / Q000517:prevention & control; D008285:Major Histocompatibility Complex; D008954:Models, Biological; D011994:Recombinant Proteins / Q000276:immunology; D012480:Salmonella Infections / Q000276:immunology / Q000517:prevention & control; D012486:Salmonella typhimurium / Q000276:immunology / Q000472:pathogenicity; D014612:Vaccines; D014614:Vaccines, Synthetic
D006681:HLA-D Antigens; D015395:Histocompatibility Antigens Class I; D011994:Recombinant Proteins; D014612:Vaccines; D014614:Vaccines, Synthetic